| 12275729 |
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Yongqi Deng, Abdelghani Achab, David Jonathan Bennett, Indu T. Bharathan, Xavier Fradera +8 more |
2025-04-15 |
|
| 12215116 |
Arginase inhibitors and methods of use |
Abdelghani Achab, Matthew L. Childers, Jared N. Cumming, Christian Fischer, Symon Gathiaka +10 more |
2025-02-04 |
|
| 11478461 |
[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors |
Liangqin Guo, Hongjun Zhang, Ping Chen, Dane Clausen, Xavier Fradera +6 more |
2022-10-25 |
$350,597,000 |
| 11352320 |
Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors |
Shuwen He, Dane Clausen, Liangqin Guo, Yongxin Han, Xianhai Huang +5 more |
2022-06-07 |
$306,734,000 |
| 11096930 |
Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase |
Phillip M. Cowley, Meredeth A. McGowan, Thomas J. Brown, Yongxin Han, Kun Liu +3 more |
2021-08-24 |
$126,043,000 |
| 11034661 |
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors |
Liangqin Guo, Yongxin Han, Kun Liu, Shuwen He, Joseph A. Kozlowski +6 more |
2021-06-15 |
$253,758,000 |
| 10988487 |
Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Kun Liu, Abdelghani Achab, Purakkattle Biju, Timothy A. Cernak, Yongqi Deng +10 more |
2021-04-27 |
$169,438,000 |
| 10927086 |
Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Kun Liu, Dane Clausen, Liangqin Guo, Yongxin Han, Shuwen He +4 more |
2021-02-23 |
$566,829,000 |
| 10538497 |
Compounds as indoleamine 2,3-dioxygenase inhibitors |
Yongxin Han, Abdelghani Achab, Purakkattle Biju, Yongqi Deng, Xavier Fradera +9 more |
2020-01-21 |
$220,499,000 |
| 10344000 |
Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof |
Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Kun Liu, Danielle F. Molinari +3 more |
2019-07-09 |
$88,734,000 |
| 9957264 |
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors |
Matthew L. Childers, Peter H. Fuller, David Joseph Guerin, Jason Katz, Mark E. Scott +11 more |
2018-05-01 |
$129,774,000 |
| 9957265 |
N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors |
Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Christopher F. Thompson, Mark E. Scott +11 more |
2018-05-01 |
$129,774,000 |
| 9725445 |
Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors |
Matthew L. Childers, Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Jason Katz +14 more |
2017-08-08 |
$65,756,000 |
| 8993756 |
Pyrrolopyrimidines as janus kinase inhibitors |
Sean P. Ahearn, Matthew Christopher, Christopher J. Dinsmore, Joon Jung, Alexey Rivkin +4 more |
2015-03-31 |
$66,424,000 |
